The Lancet

Caution on the use of α2δ-ligands in neuropathic pain – Authors' reply

We appreciate the constructive remarks by Chung-Wei Christine Lin and colleagues regarding our systematic review and resulting recommendations.1 Our systematic review and meta-analysis were explicitly ...
TipRanks on MSN

Aclarion’s NOCISCAN Study: A Potential Game-Changer for Low Back Pain Treatment

Aclarion, Inc. (($ACON)) announced an update on their ongoing clinical study. Aclarion, Inc. is conducting a multi-center randomized clinical ...
Daily

Transforaminal nerve root block effective, minimally invasive intervention for lumbar radiculopathy: study

Transforaminal nerve root block (TFNRB) is a precise local injection technique used to target a particular inflamed nerve root that causes lumbar radiculopathy for diagnostic and therapeutic purposes.
SciELO

Comparative study of long-term efficacy of spinal fusion surgery and non-surgical treatment for chronic radicular lumbar disease

OBJECTIVE: The objective of this study was to compare the long-term efficacy of spinal fusion surgery versus non-surgical treatment for chronic radicular lumbar spondylopathy. METHODS: A total of 93 ...
Frontiers

Imaging features and percutaneous endoscopic interlaminar decompression of vacuum disc phenomenon-induced lumbosacral radiculopathy: case report

Department of Spinal Surgery, Qingyuan Hospital Affiliated to Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, Guangdong, China The vacuum disc phenomenon (VDP), characterized by ...
Healio

Surgery improves outcomes of adult symptomatic lumbar scoliosis vs. nonoperative treatment

Please provide your email address to receive an email when new articles are posted on . Operative treatment of adult symptomatic lumbar scoliosis had significantly greater and durable clinical ...
Seeking Alpha

Vertex Pharmaceuticals: A Look At Their Pain Therapy Program

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain, sickle cell disease, beta thalassemia, and type 1 diabetes, with approved products in each area. Suzetrigine ...
WBAL-TV

Woman's Doctor: Painful symptoms of radiculopathy, myelopathy often overlooked in older adults

ADDITIONAL STUDIES. WELL, IN TONIGHT’S WOMAN’S DOCTOR, IF YOU’RE FEELING STIFFNESS IN YOUR NECK THAT RADIATES DOWN YOUR ARM, NUMBNESS OR TINGLING OR WEAKNESS IN YOUR HANDS, THERE ARE TWO CONDITIONS ...
verywellhealth

New FDA-Approved Painkiller Is a Safer Alternative to Opioids

The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to treat moderate-to-severe acute ...
Benzinga.com

Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) last week announced that the Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR) had met its primary endpoint. The company announced that ...
Nasdaq

Vertex Pharma’s suzetrigine meets Phase 2 primary endpoint in radiculopathy

Vertex Pharmaceuticals (VRTX) announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral ...